A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CTLars‐Olof Wahlund, Philip Scheltens, Frederik Barkhof et al.|Stroke|2001Cited by 1.8k
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon et al.|PLoS Medicine|2017Cited by 610
Inter-and Intraobserver Reproducibility of Cerebral Atrophy Assessment on MRI Scans with Hemispheric InfarctsFlorence Pasquier, Philip Scheltens, Didier Leys et al.|European Neurology|2008Cited by 539
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Martin R. Farlow et al.|Nature Medicine|2021Cited by 365
White Matter Changes on CT and MRI: An Overview of Visual Rating ScalesPhilip Scheltens, Leonardo Pantoni, Timo Erkinjunti et al.|European Neurology|1998Cited by 306